Literature DB >> 11027575

Mammalian PSP24s (alpha and beta isoforms) are not responsive to lysophosphatidic acid in mammalian expression systems.

Y Kawasawa1, K Kume, T Izumi, T Shimizu.   

Abstract

Xenopus PSP24 (xPSP24) is a G-protein-coupled receptor which was originally identified as a functional lysophosphatidic acid (LPA) receptor. We obtained two different types (alpha and beta) of mammalian homologues of xPSP24 and found that these receptors are highly expressed in the brain (Kawasawa et al., Biochem. Biophys. Res. Commun. 276, 952-956, 2000). These receptor did not respond to LPA by GTPgammaS binding assays, while Edg2 or Edg4 showed responses to LPA under the same assay conditions. Furthermore, a sensitive reporter gene assay using PC12 cells with serum response element promoter failed to detect any response of mammalian PSP24s to various concentrations of LPA. Thus, unlike xPSP24, we conclude that PSP24s are not functional LPA receptors in mammalian systems. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11027575     DOI: 10.1006/bbrc.2000.3570

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Convergence of multiple signaling cascades at glycogen synthase kinase 3: Edg receptor-mediated phosphorylation and inactivation by lysophosphatidic acid through a protein kinase C-dependent intracellular pathway.

Authors:  Xianjun Fang; Shuangxing Yu; Janos L Tanyi; Yiling Lu; James R Woodgett; Gordon B Mills
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

2.  Assessment of agonism at G-protein coupled receptors by phosphatidic acid and lysophosphatidic acid in human embryonic kidney 293 cells.

Authors:  F Alderton; B Sambi; R Tate; N J Pyne; S Pyne
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

3.  Disruption of Gpr45 causes reduced hypothalamic POMC expression and obesity.

Authors:  Jing Cui; Yi Ding; Shu Chen; Xiaoqiang Zhu; Yichen Wu; Mingliang Zhang; Yaxin Zhao; Tong-Ruei R Li; Ling V Sun; Shimin Zhao; Yuan Zhuang; Weiping Jia; Lei Xue; Min Han; Tian Xu; Xiaohui Wu
Journal:  J Clin Invest       Date:  2016-08-08       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.